Over-the-Counter CGM Biosensors Market
完整報告名稱與涵蓋範圍
Over-the-Counter CGM Biosensors Market Size, Share & Trends Analysis Report, By Product Type (OTC Glucose Biosensors for Non-Insulin Type 2 Diabetes and Prediabetes, OTC Metabolic Health and Wellness Biosensors, Consumer Apps, Coaching and Subscription Services), By Sensor Technology (Enzymatic Electrochemical Sensors, Emerging Non-Enzymatic and Multi-Analyte Sensors), By Application (Prediabetes and Non-Insulin Type 2 Diabetes Management, Weight Management and Metabolic Wellness, Sports Performance and Nutrition Optimization), By Distribution Channel, By Region, and Segment Forecasts, 2026-2035
報告摘要
The over-the-counter CGM biosensors market covers continuous glucose biosensors cleared or marketed for sale without prescription to adults with non-insulin-treated type 2 diabetes, prediabetes and consumers pursuing metabolic wellness, sports performance or weight management, together with the apps, coaching and subscription services built around them. Prescription continuous glucose monitors for insulin-treated diabetes are excluded from revenue but analysed as the technology and pricing reference.
The category was created by regulatory clearances of non-prescription biosensors in the United States and by the earlier availability of consumer glucose sensors in Europe and Asia, giving the leading monitoring companies a route to the far larger non-insulin population and to wellness consumers. Demand is fuelled by the prevalence of prediabetes, interest in personalised nutrition and metabolic health, incretin drug users seeking feedback and retail pricing below prescription products. Companies are pairing sensors with AI-driven coaching, food logging and integration with fitness platforms, while questions about clinical value in non-diabetic users, sensor accuracy expectations and reimbursement for early type 2 diabetes shape positioning. Chinese sensor makers are entering with lower-cost products across Asia and Europe.
North America and Europe lead consumer adoption, with China, India and Southeast Asia growing through affordable sensors and digital health platforms. Competition involves glucose monitoring leaders, metabolic health app companies, Chinese sensor manufacturers and wellness wearable brands.
The InsightAce study supplies US$ forecasts for all product type, sensor technology, application and distribution channel and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Over-the-Counter CGM Biosensors Market Snapshot
Chapter 4. Global Over-the-Counter CGM Biosensors Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. OTC Glucose Biosensors for Non-Insulin Type 2 Diabetes and Prediabetes
5.2.2. OTC Metabolic Health and Wellness Biosensors
5.2.3. Consumer Apps, Coaching and Subscription Services
Chapter 6. Market Segmentation 2: By Sensor Technology Estimates & Trend Analysis
6.1. Sensor Technology & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Sensor Technology:
6.2.1. Enzymatic Electrochemical Sensors
6.2.2. Emerging Non-Enzymatic and Multi-Analyte Sensors
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Prediabetes and Non-Insulin Type 2 Diabetes Management
7.2.2. Weight Management and Metabolic Wellness
7.2.3. Sports Performance and Nutrition Optimization
Chapter 8. Market Segmentation 4: By Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
8.2.1. Retail Pharmacies and Mass Merchandisers
8.2.2. Online Direct-to-Consumer
8.2.3. Digital Health and Telehealth Platforms
Chapter 9. Over-the-Counter CGM Biosensors Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Dexcom, Inc. (Stelo)
11.2. Abbott Laboratories (Lingo, Libre Rio)
11.3. Sibionics (Shenzhen Sibionics Technology Co., Ltd.)
11.4. Ultrahuman Healthcare Pvt. Ltd.
11.5. Medtrum Technologies Inc.
11.6. Infinovo Medical Co., Ltd.
11.7. Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.)
11.8. Signos, Inc.
11.9. Levels Health, Inc.
11.10. Nutrisense, Inc.
11.11. Zoe Ltd.
11.12. Supersapiens (Adjacent Sports Platforms)
11.13. Roche Diabetes Care
11.14. Senseonics Holdings, Inc.
11.15. i-SENS, Inc.
圖表清單 List of Tables & Figures
Table 1. Global Over-the-Counter CGM Biosensors Market Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global Over-the-Counter CGM Biosensors Market Segmentation Overview
Table 2. Global Over-the-Counter CGM Biosensors Market Revenue Forecast by Sensor Technology, 2026-2035 (US$ Mn)
Figure 2. Global Over-the-Counter CGM Biosensors Market Share by Product Type, 2026 & 2035
Table 3. Global Over-the-Counter CGM Biosensors Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Addressable Population for OTC Biosensors: Prediabetes, Non-Insulin Type 2 Diabetes and Wellness Users
Table 4. Global Over-the-Counter CGM Biosensors Market Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 4. Global Over-the-Counter CGM Biosensors Market Share by Sensor Technology, 2026 & 2035
Table 5. North America Over-the-Counter CGM Biosensors Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Retail and Direct-to-Consumer Pricing Relative to Prescription CGM
Table 6. Europe Over-the-Counter CGM Biosensors Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Over-the-Counter CGM Biosensors Growth Opportunity Analysis
Table 7. Asia Pacific Over-the-Counter CGM Biosensors Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Sensor Plus Coaching Business Models and Subscription Economics
Table 8. Latin America Over-the-Counter CGM Biosensors Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Over-the-Counter CGM Biosensors Market Participants
Table 9. Middle East & Africa Over-the-Counter CGM Biosensors Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們